Showing results (331-340 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|August 18, 2022
Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential TherapyHidekatsu Kuroda, Takayoshi Oikawa, Masashi Ninomiya, et al.
Liver Cancer|August 18, 2022
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular CarcinomaMasatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda, et al.
Liver Cancer|August 11, 2022
Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert StatementsYongkun Sun, Wen Zhang, Xinyu Bi, et al.
Liver Cancer|May 12, 2021
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationClaudia Campani, Alessandro Vitale, Gabriele Dragoni, et al.
Liver Cancer|May 13, 2021
MRI Features for Predicting Microvascular Invasion of Hepatocellular Carcinoma: A Systematic Review and Meta-AnalysisSeung Baek Hong, Sang Hyun Choi, So Yeon Kim, et al.
Liver Cancer|August 20, 2021
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular CarcinomaFrancesco Tovoli, Vincenzo Dadduzio, Stefania De Lorenzo, et al.
Liver Cancer|March 6, 2023
Dietary Fat Composition Affects Hepatic Angiogenesis and Lymphangiogenesis in Hepatitis C Virus Core Gene Transgenic MicePan Diao, Yaping Wang, Fangping Jia, et al.
Liver Cancer|October 20, 2025
Erratum
Liver Cancer|October 9, 2025
Tumor Mutational Burden as a Prognostic Biomarker for Relapse-Free Survival in Hepatocellular Carcinoma: Insights from Long-Term Follow-UpYuya Miura, Yukiyasu Okamura, Keiichi Ohshima, et al.
Liver Cancer|October 9, 2025
Detection and Characterization of Subcentimeter Hepatocellular Carcinoma: A Comparison of Gadoxetic Acid-Enhanced and Extracellular Contrast Agent-Enhanced MRIYuyao Xiao, Peng Huang, Cheng Wang, et al.
Pageof 55